HANNAH STONE: Open Payments
NPI 1467968966 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 22 payments from 9 companies in 2025. Trend: 2023 $382 · 2024 $137 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $274 |
| Sumitomo Pharma America, Inc. | 3 | $76 |
| Astellas Pharma US Inc | 2 | $68 |
| Sage Therapeutics, LLC | 2 | $47 |
| MILLICENT US INC | 2 | $40 |
| ABBVIE INC. | 2 | $40 |
| Exeltis, USA Inc. | 2 | $38 |
| CooperSurgical, Inc. | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $10 |
Products named: ANNOVERA, GEMTESA, Veozah, ZURZUVAE, LILETTA, SLYND, INTRAROSA, Paragard T 380A.
Industry payments across CA — which companies pay providers there.
